Ordering
Available Variants5 mg
CHA.42773-5mg
Price
€426.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.42773-5mg | €426.40 |
from Streptomyces parvulus, ≥97% (HPLC), Ras farnesyltransferase inhibitor, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C31H38N2O7 |
|---|---|
| CAS Number | 52665-74-4 |
| Molecular Weight | 550.64 |
| UNSPSC Code | 12352200 |
| PubChem Substance ID | 24897011 |
| NACRES | NA.32 |
| MDL number | MFCD00920782 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
Manumycin A, with a CAS number of 52665-74-4, is a naturally occurring compound that has garnered significant attention in the scientific community due to its potential therapeutic applications. This sesquiterpene quinone, isolated from Streptomyces parvulus, exhibits a broad spectrum of biological activities, including antibacterial, antifungal, and antitumor properties. Research has demonstrated that Manumycin A can inhibit the growth of various cancer cell lines, making it a promising candidate for cancer therapy. Additionally, its ability to interfere with protein prenylation, a crucial process in cellular signaling pathways, has sparked interest in its potential to treat diseases related to aberrant cell signaling. Further studies are necessary to fully elucidate the mechanisms of action and potential clinical applications of Manumycin A, but its unique properties make it an intriguing compound for ongoing research and development.
